Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis

Hepatology Research

Volumn 38, Issue 4, 2008, Pages 325-334

  Nakanuma, Yasuni ^a   Sasaki, Motoko ^a   Ikeda, Hiroko ^a   Sato, Yasunori ^a   Zen, Yoh ^b   Kosaka, Kazuto ^a   Harada, Kenichi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bile ductules; Cholangiocarcinoma; Intrahepaticbile ducts; Progenitor cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NERVE CELL ADHESION MOLECULE; VIMENTIN;

ADENOCARCINOMA; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CARCINOGENESIS; CELL DIFFERENTIATION; DISEASE COURSE; HEPATOBILIARY SYSTEM; HISTOPATHOLOGY; HUMAN; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL;

EID: 40049089909     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00312.x     Document Type: Review

References (32)

1. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology. J Gastroenterol Hepatol 2002; 17: 1049-55.
2. Nakanuma Y, Sripa B, Batanasapt V, Leong ASY, Ponchon T, Ishak KG. Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics. Tumours of the Digestive System. World Health Organization of Tumours. Lyon: IARC Press, 2000; 173-80.
3. Wittekind C, Fischer HP, Ponchon T. Combined hepatocellular and cholangiocarcinoma. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics. Tumours of the Digestive System. World Health Organization of Tumours. Lyon: IARC Press, 2000; 181.
4. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: Recent progress. Part 2: Molecular pathology and treatment. J Gastroenterol Hepatol 2002; 17: 1056-63.
5. Kozaka K, Sasaki M, Fujii T etal. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: "bile ductular carcinoma". Histopathology 2007; 51: 390-400.
6. Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 1997; 38: 552-70.
7. Roskams TA, Theise ND, Balabaud C etal. Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers. Hepatology 2004; 39: 1739-45.
8. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25: 3818-22.
9. Asayama Y, Aishima S, Taguchi K etal. Coexpression of neural cell adhesion molecules and bcl-2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: Relationship to atypical reactive bile ductule. Pathol Int 2002; 52: 300-6.
10. Nakanuma Y, Kono N. Expression of vimentin in proliferating and damaged bile ductules and interlobular bile ducts in non-neoplastic hepatobiliary diseases. Mod Pathol 1992; 5: 550-4.
11. Kim H, Park C, Han KH etal. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 2004; 40: 298-304.
12. Nakanuma Y, Terada T, Tanaka Y etal. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch A Pathol Anat Histopathol 1985; 406: 45-58.
13. Zen Y, Sasaki M, Fujii T etal. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct -an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 2006; 44: 350-8.
14. Terada T, Nakanuma Y, Ohta T etal. Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis. Histopathology 1992; 21: 233-40.
15. Ishikawa A, Sasaki M, Ohira S etal. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest 2004; 84: 629-38.
16. Yamamoto S, Kubo S, Hai S etal. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004; 95: 592-5.
17. Sasaki M, Tsuneyama K, Ishikawa A, Nakanuma Y. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. Hum Pathol 2003; 34: 1337-44.
18. Terada T, Nakanuma Y. Development of human intrahepatic peribiliary glands. Histological, keratin immunohistochemical, and mucus histochemical analyses. Lab Invest 1993; 68: 261-9.
19. Steiner PE, Higginson J. Cholangiolocellular carcinoma of the liver. Cancer 1959; 12: 753-9.
20. Yamamoto M, Takasaki K, Nakano M, Saito A. Hepatic recurrence of cholangiolocellular carcinoma: Report of a case. Hepatogastroenterology 1996; 43: 1046-50.
21. Shiota K, Taguchi J, Nakashima O, Nakashima M, Kojiro M. Clinicopathologic study on cholangiolocellular carcinoma. Oncol Rep 2001; 8: 263-8.
22. Omata M, Peters RL, Tatter D. Sclerosing hepatic carcinoma: Relationship to hypercalcemia. Liver 1981; 1: 33-49.
23. Theise ND, Yao JL, Harada K etal. Hepatic "stem cell" malignancies in adults: Four cases. Histopathology 2003; 43: 263-71.
24. Shimonishi T, Miyazaki K, Nakanuma Y. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver. Histopathology 2000; 37: 55-63.
25. Tot T. Adenocarcinomas metastatic to the liver: The value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 1999; 85: 171-7.
26. Libbrecht L. Hepatic progenitor cells in human liver tumor development. World J Gastroenterol 2006; 12: 6261-5.
27. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 2001; 25: 1388-96.
28. Malhi H, Gores GJ. Cholangiocarcinoma: Modern advances in understanding a deadly old disease. J Hepatol 2006; 45: 856-67.
29. Lee JS, Heo J, Libbrecht L etal. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006; 12: 410-16.
30. Qiu FH, Ray P, Brown K etal. Primary structure of c-kit: Relationship with the CSF-1/PDGF receptor kinase family -oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 1988; 7: 1003-11.
31. Heidel F, Cortes J, Rucker FG etal. Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib. Cancer 2007; 109: 907-14.
32. Alison MR. Liver stem cells: Implications for hepatocarcinogenesis. Stem Cell Rev 2005; 1: 253-60.